carbazilquinone has been researched along with Leukocytopenia in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, K | 1 |
| Hino, M | 1 |
| Kurane, S | 1 |
| Yano, T | 1 |
| Niitani, H | 1 |
| Yamano, Y | 1 |
| Hasegawa, K | 1 |
| Tuboi, E | 1 |
1 trial available for carbazilquinone and Leukocytopenia
| Article | Year |
|---|---|
[A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carcinoma, Small Cell; | 1989 |